News The latest developments in autism research.
Profiles Portraits of scientists who are making a mark on autism research.
Toolbox Emerging tools and techniques that may advance autism research.
Spotted A roundup of autism papers and media mentions you may have missed.
Opinion Conversations on the science of autism research.
Viewpoint Expert opinions on trends and controversies in autism research.
Columnists Dispatches from experts on various facets of autism.
Crosstalk Debates and conversations about timely topics in autism.
Reviews Exploring the intersection of autism and the arts.
Q&A Conversations with experts about noteworthy topics in autism.
Deep Dive In-depth analysis of important topics in autism.
Special Reports Curated collections of articles on special topics in autism.
Webinars Presentations by leading experts on their latest research.
News

Large genetic registry may uncover autism’s diverse origins

by  /  21 April 2016
Spit sample: Researchers plan to sequence DNA from the saliva of 50,000 people with autism.

Bobby Lopez

Autism researchers are reaching out to families to build the nation’s biggest repository of genetic information to date from individuals with the condition.

Unveiled today, the ambitious new project, called SPARK, aims to gather information from 50,000 people with autism, along with their relatives. (SPARK is funded by the Simons Foundation, Spectrum’s parent organization.) About 500 families signed up to participate during the project’s pilot phase, launched in December.

The participants can mail in saliva samples for genetic testing — a convenience that could attract people who are currently underrepresented in research studies, such as minorities and those who have severe symptoms, says lead investigator Wendy Chung, assistant professor of pediatrics at Columbia University in New York.

Some of these groups tend not to participate in research because of the time commitment, cost of travel or stress involved. But without a large and diverse pool of participants, researchers cannot identify the various causes of autism, says Jeremy Parr, clinical senior lecturer at Newcastle University in the United Kingdom, who is not involved with the project. Parr works with the Autism Spectrum Database-UK, a registry of clinical information from more than 1,000 families that have a child with autism.

Even when recruitment is complete, the project will represent only a small fraction of the estimated 3.5 million Americans who have autism1. Still, the project’s size is a “significant step forward,” Parr says.

Simple sign-up:

To participate in SPARK, individuals with autism or their caregivers must provide demographic information, describe their extended family’s medical and psychiatric histories and complete the Social Communication Questionnaire, which measures social skills, all via an online portal. The family also uploads each participating member’s health records and confirms, by checking a box, that the person with autism has a clinical diagnosis. Participants can also register in person at one of the project’s 21 sites.

“The ability of so many individuals to get online, either on their smart phones or from work or home, has allowed us to do things that we could not have done five years ago,” says Chung.

However, not everyone has access to this technology, and the project may end up leaving out some of the participants whom researchers most want to reach. “It may miss patients who have a socioeconomic disadvantage,” says Nalin Payakachat, associate professor of pharmacy at the University of Arkansas for Medical Sciences in Little Rock, who is not involved in the project.

Although uploading medical histories online is convenient, “it may not be as reliable as enrolling patients from clinics and obtaining their medical information from medical records,” she adds.

To meet their interim goal of enrolling 10,000 participants by next year, the researchers are using recruitment tactics ranging from hosting events to posting on social media. Once enrolled, participants ship saliva samples (using a kit) to one central lab for analysis. Researchers then extract DNA and sequence the protein-coding portion of each genome.

“It’s about as easy as anyone could make it,” says Dianna Varady, director of the Arkansas Autism Resource and Outreach Center and mother of a 12-year-old boy with autism. The researchers plan to share the genetic results with families, which might help them make decisions about treatment, Varady says.

Revealing relationships:

A key aspect of the project is scientists’ ability to recruit registered members for future studies. The participants update their information each year, which should create a “richer, deeper and more dimensional” resource over time, says Chung.

Because of the group’s size, researchers may also be able to probe relationships between genes and clinical symptoms. For example, Stephen Kanne’s team at the University of Missouri plans to analyze the data to understand how autism genes might contribute to language development or responses to treatment. And Robin Kochel’s team at Texas Children’s Hospital aims to use demographic information from the participants to examine how a family’s cultural beliefs and geographical location might influence its members’ approach to intervention.

Another registry, the Interactive Autism Network (IAN), has also collected behavioral and clinical information through online surveys of 20,000 people with autism plus their family members. However, most IAN members have not provided any genetic samples.

Some of the participants are likely to be members of other registries, such as IAN or the National Database for Autism Research. The researchers can pinpoint these participants because each carries a unique identifier, or GUID.

By cross-referencing data from these registries for each participant, researchers might be able to piece together a complete portrait of families with autism. Using such a strategy, Payakachat says, “can catalyze relationships not envisioned by the original data collectors.”

With additional reporting by Nicholette Zeliadt.

Corrections

This article has been modified from the original. The previous version incorrectly suggested that the project only allows participants to enroll online, that saliva samples will be analyzed at the 21 participating research centers, and that all of IAN’s 54,000 participants have autism.


References:
  1. Buescher A.V. et al. JAMA Pediatr. 168, 721-728 (2014) PubMed
  • This is a good idea, and I hope people participate. I applaud what the Simons Foundation has done with the existence of Spectrum. On this initiative, I do wish that the Simons Foundation would apply more of their autism research funding to projects that go beyond genes. Genetic complexity is significant even when ignoring nongenetic factors. Since epigenetic factors and environmental factors also play significant roles in biochemistry which drives neurology, it would appear that any studies which look at genetics alone will have limited utility for a large number of those with autism. Biochemistry is also easier to manipulate than genetics in those who are already affected. Therefore, it seems to me that studies on biochemistry are likely to be much more revealing in terms of understanding and bring us closer to developing meaningful therapeutics than studies on genetics. So in my view, it would be wonderful if the Simons Foundation or some other major institution which funds autism research got behind an effort to collect and make available to researchers biochemical information on a large number of people with autism.

    Seth Bittker
    Autism Research Connections

  • Julia Sommer

    Hi Seth, thanks for your comment. I agree with you that biochemical pathways are were drugs actually function. The reason that genetics is so important, is that it can lead us towards those biochemical pathways that might be changed in ASDs. There is also the possibility that some of the genetics converge on specific biochemical pathways, and therefore different forms of ASD might respond to treatment with the same drug although they have different genetic causes. So, it’s not genetics OR biochemistry, it’s genetics AND biochemistry, they really go hand in hand. I think it’s also worth mentioning that what’s so special about the SPARK cohort described in this article is that individuals in this cohort agree to be re-contactable and can participate in future studies e.g. on environmental risk factors. Having the genetics as well, will allow e.g. research on gene x environment interactions etc.

  • Autism Mom

    Simons is tremendously generous to the autism community. The staffers are brilliant but I have to wonder if they are actively engaged in caring for or teaching ASD people? There is no enthusiasm for genetics only research among families, none. Families have been promised big breakthrough are around the corner for a decade and nothing changes in their child’s life. Studying genes in context to environmental factor creates real richness and value for researchers and families. For example the MTHFR gene….I would love to see this ASD carriers of this gene studied for immune dysfunction overlap.

    • Cathy

      Oh Jeezus, the MTHFR gene.

      If you’re just joining “Autism Mom” is none other than Katie Wright of Generation Rescue. Or, as we affectionately call her, just another ignorant troll.

close

Log in to your Spectrum Wiki account

Email Address:

Password:


close

Request your Spectrum Wiki account

Spectrum Wiki is a community of researchers affiliated with an academic or research institutions. To be considered for participation, please fill out this form and a member of our team will respond to your request.

Name:

Email Address:

Title and Lab:

Area of Expertise:

Comments: